MediLiVes aims to disrupt the healthcare & telemedicine industry by lowering the cost & barrier in conducting algorithmic medical examination models. MediLiVes has brought an opportune moment for a major and much-needed disruption of the current healthcare system. With telemedicine infusion with technology, doctors and patients alike can manage care remotely, increasing efficiency and outcomes. Medi-Science International Ltd is an official provider and distributor of Medi-Science technology called Analytical Telemedicine System MediLiVes. Medi-Science International Ltd is also the official entity involved in the preparation and execution of the MediLiVes IEO project. It is an innovative company offering unique, new-generation telemedicine solutions. Telemedicine, based on technology that enables a patient’s health condition to be monitored from a distance, is one of the fastest-growing industries in the world.